Immunotherapy for high-grade glioma
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-05-01 / Future Oncol 2014 May;10(6):911-5Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2014-04-29 / Cancer Immunol. Immunother. 2014 Aug;63(8):797-806Colorectal cancer and immunity: what we know and perspectives
/in Dendritic Cells, International Publications /von 2014-04-14 / World J. Gastroenterol. 2014 Apr;20(14):3738-50SnapShot: cancer vaccines
/in Dendritic Cells, International Publications /von 2014-04-10 / Cell 2014 Apr;157(2):516-516.e1Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients
/in Colorectal Cancer, Dendritic Cells, Gastric Cancer, International Publications /von 2014-04-03 / PLoS ONE 2014;9(4):e93886Current vaccine trials in glioblastoma: a review
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-04-03 / J Immunol Res 2014;2014:796856Novel approaches and mechanisms of immunotherapy for glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-03-01 / Discov Med 2014 Mar;17(93):145-54Natural killer cells: the secret weapon in dendritic cell vaccination strategies
/in Dendritic Cells, International Publications /von 2014-03-01 / Clin. Cancer Res. 2014 Mar;20(5):1095-103Phase I dendritic cell p53 peptide vaccine for head and neck cancer
/in Dendritic Cells, International Publications /von 2014-02-28 / Clin. Cancer Res. 2014 May;20(9):2433-44
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de